|
Cancer Monoclonal Antibodies Market Forecast to 2017
PR Newswire (press release) According to RNCOS’ report, “Cancer Monoclonal Antibodies Market Forecast to 2017″, the market for cancer mAbs is estimated at US$ 23 Billion, and is expected to grow to US$ 33 Billion by 2017. The report, in particular, provides an insight to the … |
Lilly Phase III Candidate Meets Primary Endpoint of NSCLC Overall SurvivalGenetic Engineering NewsEnzastaurin reportedly failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of DLBCL …
|
Government of Ontario’s Ministry of Health Approval of the Reimbursement of …
Canada NewsWire (press release) 13, 2013 /CNW/ – The Canadian Pemphigus and Pemphigoid Foundation (CPPF) applauds the Government of Ontario’s Ministry of Health and Long-Term Care decision to fund Rituxan (Rituximab) for the treatment of Pemphigus Vulgaris through the Ontario … |
Vaccine News Daily |
FDA approves test that detects HIV antibodies
Vaccine News Daily The Alere Determine HIV-1/2 Ag/Ab Combo test is used to detect HIV-1 p24 antigen as well as antibodies to both HIV-1 and HIV-2 in human serum, plasma, venous and whole blood specimens. It is the first FDA-approved test that can distinguish between the … FDA approves Alere Determine HIV-1/2 Ag/Ab Combo for detection of HIV …News-Medical.net FDA OKs First Rapid Test That Can Detect Acute HIVAIDSmeds.com HIV/AIDS Treatment News Newman Ferrarra LLP | DETECTING HIV-1 ANTIGENSLinex Legal (press release) (registration) Proactive Investors USA & Canada all 37 news articles » |
ThomasNet News (press release) |
Reagent Kits deliver probes, antibodies into cells.
ThomasNet News (press release) INDIANAPOLIS — PerFix-Expose1 and PerFix-nc1, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivershigh quality results. Developed for use on … |
|
PlantForm gets more funding for HIV antibodies
Guelph Mercury GUELPH — The second phase of PlantForm’s development of antibodies for human immunodeficiency virus (HIV) has received a significant second round of funding from the National Research Council of Canada. The local company is progressing on a … |
|
EU5 rheumatologits rate Rituxan and Benlysta for Lupus
The Pharma Letter Rheumatologists in the top European nations ( EU5) countries (France, Germany, Italy, Spain, UK) give Roche (ROG: SIX)/Genentech/Biogen Idec’s (Nasdaq: BIIB) Rituxan (rituximab) and GlaxoSmithKline (LSE: GSK)/Human Genome Sciences’ Benlysta … |
|
Burkitt Lymphoma Survival Improves For Some
Insciences Organisation The same regimen of intensive chemotherapy and the monoclonal antibody rituximab are recommended for most patients. “There was little available for Burkitt lymphoma in terms of prognostic factors, indicators, or scoring,” said Dr. Jorge Castillo … |
UPI.comCamels linked to Middle East respiratory syndrome coronavirusUPI.com9 (UPI) — Antibodies specific to Middle East respiratory syndrome coronavirus were found in all samples from dromedary camels in Oman, researchers in the Netherlands say. Dr. C…
The IN VIVO Blog (blog) |
Deals Of The Week: Isis Rethinks Its Partnering Strategy
The IN VIVO Blog (blog) … arthritis drug Humira (adalimumab). The collaboration will involve biosimilar versions of four oncology drugs, including Roche/Genentech Inc.’s Rituxan (rituximab), Bristol-Myers Squibb Co./Eli Lilly & Co.’s Erbitux (cetuximab), Roche/Genentech’s … |